. Antibody validation of pS935 and total LRRK2 used in this study.
(a) Primary cultured neurons from non-transgenic WT C57BL/6J and LRRK2 -/-KO mice at 14 DIV treated with DMSO, 1 μM LRRK2-IN1 or 300 μM IC261 for 2 hrs. Samples were subjected to SDS-PAGE and immunoblotted for pS935 and total LRRK2. Given that the detected pS935 signal was weaker in primary cultured neuron ( Fig. 2e ) compared to overexpression in 293FT cells, we validated the antibodies using LRRK2-KO cultures. The antibody used was specific for pS935 and total endogenous LRRK2 as the detected band in non-transgenic WT was absent in LRRK2-KO cultures.
(b) Ex vivo acute brain slices from 4-9 weeks old non-transgenic WT C57BL/6J and LRRK2 -/-KO mice treated with DMSO, 1 μM LRRK2-IN1 or 300 μM IC261 and analyzed as in primary cultured neurons.
One brain slice per mouse was used per treatment group, that is one half of the brain slice was treated with DMSO and the other half with either IC261 (#1) or LRRK2-IN1 (#2). Results were consistent with 3a showing antibody specificity to pS935 and total endogenous LRRK2 in non-transgenic WT whereas no signal was detected in LRRK2-KO brain slices. phosphorylation by WEE1 was not due to lack of WEE1 kinase activity, we performed an in vitro autophosphorylation assay to check if the WEE1 used was enzymatically active. WEE1 is able to autophosphorylate to a similar extent, if not more, as CK1α. (c) LRRK2 can be phosphorylated by other CK1 isoforms but to a lesser extent compared to CK1α. In vitro kinase assay was performed in a similar setup as in 4a for LRRK2 with each CK1 isoforms (alpha, delta, epsilon, gamma 1, gamma 2, gamma 3). Phosphorylation at S910, S935 and 955 is strongest for CK1α compared to the other five isoforms.
Supplementary
(d) Quantitation of blots in 5c. Graph shows mean +/-SEM (n=3) for % pS935 phosphorylation (relative to DMSO control) for each CK1 isoform. (e) Knockdown of CK1α with the pooled CSNK1A1 siRNA did not affect the expression of the other CK1 isoforms (delta, epsilon, gamma 1) implying that the loss of pS935 is due to CK1α knock down and unlikely due to an off-target effect by the other CK1 isoforms.
(f) Quantitation of blots in 5e. Graph shows mean +/-SEM (n=3) for % CK1 level (relative to NTC control) for each CK1 isoform. 

